A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients

BMC Nephrology

Bergur V. Stefánsson³  Nils-Olov Stålhammar³  Donna E. Jensen¹  Karthik Ramakrishnan¹  Emmanuel Anum¹  David Rosenbaum²  Steven M. Brunelli¹  Claudia Cabrera³ 

[1] DaVita Clinical Research®, Minneapolis, MN, USA;Ardelyx, Inc, Fremont, CA, USA;AstraZeneca, R&D, Mölndal, SE-43183, Sweden

关键词: Hemodialysis;    Heart disease;    Volume overload;    Heart failure;    Fluid accumulation;    Chronic kidney disease;    Cardiovascular death;    Blood pressure;   

Others  :  1220815
DOI  :  10.1186/s12882-015-0110-9

 received in 2015-02-12, accepted in 2015-07-14,  发布年份 2015

【 摘 要 】

Background

Greater interdialytic weight gain (IDWG) is associated with risk of all-cause mortality and hospitalization. Dialysis patients are also at greater risk of cardiovascular (CV) events than patients without kidney disease. This retrospective study examined the potential association between IDWG and specific types of CV events.

Methods

Data were obtained from United States Renal Data System claims and the electronic health records of Medicare patients who initiated hemodialysis between 01 January 2007 and 31 December 2008 at a large dialysis organization. Absolute IDWG was defined as predialysis weight minus postdialysis weight from the prior treatment, and relative IDWG was calculated as percentage of postdialysis weight with mean values for each, calculated over dialysis days 91 to 180. Patient outcomes were considered beginning on day 181, continuing until death, discontinuation of care, censoring, or study end (31 December 2009). Outcomes included all-cause mortality, CV mortality, hospitalization for nonfatal heart failure/volume overload, hospitalization for nonfatal myocardial infarction, MACE (a composite measure of nonfatal myocardial infarction, nonfatal ischemic stroke, or CV death), and MACE+ (events comprising MACE as well as arrhythmia, nonfatal hemorrhagic stroke, or hospitalization for heart failure). Associations between IDWG and outcomes over the exposure period were estimated using proportional hazards regression and adjusted for baseline characteristics.

Results

39,256 patients qualified for analysis. In general, associations of relative IDWG with outcomes were more potent, consistent, and monotonic than those for absolute IDWG. Relative IDWG > 3.5 % body weight was independently associated with all outcomes studied: point estimates ranged from 1.18 (myocardial infarction) to 1.26 (CV mortality) and were consistent among patients with and without diabetes, and with and without baseline heart failure. Absolute IDWG > 3 kg was associated with outcomes other than myocardial infarction: point estimates ranged from 1.11 (MACE) to 1.20 (heart failure).

Conclusions

Greater IDWG is associated with an increased risk of CV morbid events. Strategies that mitigate IDWG may improve CV health and survival among hemodialysis patients.

【 授权许可】

   
2015 Cabrera et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

【 参考文献 】

• [1]2013 Annual Data Report: Incidence, Prevalence, Patient Characteristics, and Treatment Modalities. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda; 2013.
• [2]2013 Annual Data Report: Hospitalizations. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda; 2013.
• [3]Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB, Fonarow GC. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation. 2009; 119(5):671-679.
• [4]Flythe JE, Curhan GC, Brunelli SM. Disentangling the ultrafiltration rate-mortality association: the respective roles of session length and weight gain. Clin J Am Soc Nephrol. 2013; 8(7):1151-1161.
• [5]Foley RN, Herzog CA, Collins AJ. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney International. 2002; 62(5):1784-1790.
• [6]Stefansson BV, Brunelli SM, Cabrera C, Rosenbaum D, Anum E, Ramakrishnan K, Jensen DE, Stalhammar NO. Intradialytic hypotension and risk of cardiovascular disease. Clinical Journal of the American Society of Nephrology. 2014; 9(12):2124-2132.
• [7]Holmberg B, Stegmayr BG. Cardiovascular conditions in hemodialysis patients may be worsened by extensive interdialytic weight gain. Hemodial Int. 2009; 13(1):27-31.
• [8]Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995; 51(2):524-532.
• [9]Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004; 15(5):1307-1315.
• [10]Movilli E, Gaggia P, Zubani R, Camerini C, Vizzardi V, Parrinello G, Savoldi S, Fischer MS, Londrino F, Cancarini G. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transplant. 2007; 22(12):3547-3552.
• [11]Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J et al.. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int. 2006; 69(7):1222-1228.
• [12]Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol. 2009; 4(5):914-920.
• [13]Stegmayr BG, Brannstrom M, Bucht S, Dimeny E, Ekspong A, Granroth B, Grontoft KC, Hadimeri H, Holmberg B, Ingman B et al.. Minimized weight gain between hemodialysis contributes to a reduced risk of death. Int J Artif Organs. 2006; 29(7):675-680.
• [14]Flythe JE, Brunelli SM. The risks of high ultrafiltration rate in chronic hemodialysis: implications for patient care. Semin Dial. 2011; 24(3):259-265.
• [15]Zoccali C, Torino C, Tripepi R, Tripepi G, D' Arrigo G, Postorino M, Gargani L, Sicari R, Picano E, Mallamaci F. Pulmonary congestion predicts cardiac events and mortality in ESRD. J Am Soc Nephrol. 2013; 24(4):639-646.
• [16]Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode C, Malecka-Masalska T, Marcelli D. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009; 24(5):1574-1579.
• [17]Hur E, Yildiz G, Budak Kose S, Kokturk F, Musayev O, Gungor O, Magden K, Yildirim I, Duman S, Ok E. Bioimpedance and echocardiography used interchangeably in volume comparison of dialysis patients. Hippokratia. 2012; 16(4):329-334.
• [18]Lee MJ, Doh FM, Kim CH, Koo HM, Oh HJ, Park JT, Han SH, Yoo TH, Kim YL, Kim YS et al.. Interdialytic weight gain and cardiovascular outcome in incident hemodialysis patients. American Journal of Nephrology. 2014; 39(5):427-435.
• [19]Testa A, Beaud JM. The other side of the coin: interdialytic weight gain as an index of good nutrition. American Journal of Kidney Disease. 1998; 31(5):830-834.
• [20]2013 Annual Data Report: Mortality. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda; 2013.
• [21]Hecking M, Karaboyas A, Antlanger M, Saran R, Wizemann V, Chazot C, Rayner H, Horl WH, Pisoni RL, Robinson BM et al.. Significance of interdialytic weight gain versus chronic volume overload: consensus opinion. Am J Nephrol. 2013; 38(1):78-90.
• [22]Agarwal R. Volume overload in dialysis: the elephant in the room, no one can see. American Journal of Nephrology. 2013; 38(1):75-77.